Effect of sodium valproate on mania

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Archives of Psychiatry and Neurological Sciences

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/BF00343800PMID 6778456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GABA blockade, dopamine and schizophrenia: Experimental studies in the cat

  2004cited by this paper
• High dose diazepam in schizophrenia

  2004cited by this paper
• Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study

  2004cited by this paper
• Handbook of Lithium Therapy

  1980cited by this paper
• Regional Alterations in Rat Brain Neurotransmitter Systems Following Chronic Lithium Treatment

  1980cited by this paper
• Ethanol and other CNS depressants decrease GABA synthesis in mouse cerebral cortex and cerebellum in vivo.

  1980cited by this paper
• Evidence for an action of sodium ions in the activation of contraction of twitch muscle fibre

  1979cited by this paper
• Acute hepatic failure associated with the use of sodium valproate.

  1979cited by this paper
• Action of d-propranolol in manic psychoses

  1979cited by this paper
• Reye-like syndrome associated with valproic acid therapy.

  1979cited by this paper
• THE EFFECT OF DELTA‐AMINOLAEVULINIC ACID ON THE UPTAKE AND EFFLUX OF [3H]GABA IN RAT BRAIN SYNAPTOSOMES

  1979cited by this paper
• Action of Propranolol in Mania: Comparison of Effects of the d- and the l-stereoisomer

  1979cited by this paper
• Difference in behaviour between synthetic and endogenous substance P in human plasma

  1979cited by this paper
• Modulatory effects of baclofen muscimol and GABA on interspecific aggressive behaviour in the rat.

  1978cited by this paper
• The measurement of change in endogenous affective disorders

  1978cited by this paper
• Effect of valproic acid on hepatic function

  1978cited by this paper
• Pharmacokinetics of sodium valproate in dog and mouse.

  1978cited by this paper
• Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone

  1977cited by this paper
• gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.

  1977cited by this paper
• GABA stimulation and blockade in the hypothalamus and midbrain: effects on feeding and locomotor activity.

  1977cited by this paper
• Diphenylhydantoin prolongs postsynaptic inhibition and iontophoretic GABA action in the crayfish stretch receptor.

  1977cited by this paper
• Pharmacokinetic studies with valproic acid in man.

  1977cited by this paper
• Baclofen (para-chlorphenyl-GABA) in Schizophrenia*

  1977cited by this paper
• Sodium Valproate: A Review of its Pharmacological Properties and Therapeutic Efficacy in Epilepsy

  1977cited by this paper
• gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.

  1977cited by this paper
• Wirkung des Beta-Rezeptoren-Blockers Propranolol auf Manien

  1976cited by this paper
• Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.

  1976cited by this paper
• [The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)].

  1976cited by this paper
• Inhibitory effects of propranolol and oxprenolol on excitation induced by a MAO inhibitor and reserpine in the mouse.

  1976cited by this paper
• [Dipropylacetamide in the treatment of manic-depressive psychosis].

  1975cited by this paper
• [Psychoses in epilepsy--classification and EEG-studies (author's transl)].

  1975cited by this paper
• The inhibitory effect of sodium n‐dipropyl acetate on the degradative enzymes of the GABA shunt

  1975cited by this paper
• The prevention of ethanol withdrawal seizures in rats by dipropylacetate.

  1975cited by this paper
• New concepts on the mechanism of action of benzodiazepines.

  1975cited by this paper
• BACLOFEN IN THE TREATMENT OF SCHIZOPHRENIA

  1975cited by this paper
• [Psychoses in epilepsy--classification and EEG-studies (author's transl)].

  1975cited by this paper
• Letter: Baclofen in the treatment of schizophrenia.

  1975cited by this paper
• Central effects of beta-(para-chlorophenyl)-gamma-aminobutyric acid.

  1974cited by this paper
• The quantitation of manic behavior.

  1974cited by this paper
• PROPERTIES OF BRAIN l‐GLUTAMATE DECARBOXYLASE: INHIBITION STUDIES 1

  1974cited by this paper
• The action of beta-phenyl-GABA derivatives on neurones of the cat cerebral cortex.

  1974cited by this paper
• [Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].

  1974cited by this paper
• Behandlung von akuten schizophrenen Psychosen mit Beta-Receptoren-Blockern

  1974cited by this paper
• Central effects of -(p-chlorophenyl)-?-aminobutyric acid

  1974cited by this paper
• The action of β-phenyl-GABA derivatives on neurones of the cat cerebral cortex

  1974cited by this paper
• The Role of γ-Aminobutyric Acid Metabolism in the Regulation of Cerebral Excitability

  1974cited by this paper
• Psychological measurements in psychopharmacology

  1974cited by this paper
• Anti‐Manic and Prophylactic Effects of Carbamazepine (Tegretol) on Manic Depressive Psychosis A Preliminary Report

  1973cited by this paper
• [Use of propranolol in acute intermittent porphyria].

  1973cited by this paper
• Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia.

  1972cited by this paper
• Further studies with propranolol in psychotic patients

  1972cited by this paper
• [Long-term thymoregulative action of Depamide in manic-depressive psychoses].

  1971cited by this paper
• TREATMENT OF ACUTE PORPHYRIA VARIEGATA WITH PROPRANOLOL

  1970cited by this paper
• Treatment of acute prophyria variegata with propranolol.

  1970cited by this paper
• [Neuropsychotropic action of a new anti-epileptic agent: depamide].

  1966cited by this paper
• The use of dilantin in the treatment of psychotic patients unresponsive to other treatment.

  1946cited by this paper
• The use of dilantin in the treatment of psychotic patients unresponsive to other treatment.

  1946cited by this paper

• Effect of γ-tACS on prefrontal hemodynamics in bipolar disorder: A functional near-infrared study.

  2024cites this paper
• Human-Induced Pluripotent Stem Cell (iPSC)-Derived GABAergic Neuron Differentiation in Bipolar Disorder

  2024cites this paper
• The efficacy of valproate in acute mania, bipolar depression and maintenance therapy for bipolar disorder: an overview of systematic reviews with meta-analyses

  2024cites this paper
• Intervention effects of Naoxintong capsules on psychological and cardiac status in depressed rats after heart failure

  2024cites this paper
• How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?

  2023cites this paper
• Histone Deacetylase Inhibitors (HDACi) Increase Expression of KCa2.3 (SK3) in Primary Microvascular Endothelial Cells.

  2022cites this paper
• Neuronal imbalance of excitation and inhibition in schizophrenia: a scoping review of gamma‐band ASSR findings

  2022cites this paper
• Valproate, divalproex, valpromide: Are the differences in indications justified?

  2022cites this paper
• Criss‐crossing autism spectrum disorder and adult neurogenesis

  2021cites this paper
• A Novel and Reliable Rat Model of Autism

  2021cites this paper
• Vitamin A supplementation ameliorates motor incoordination via modulating RORα in the cerebellum in a valproic acid-treated rat autism model with vitamin A deficiency.

  2021cites this paper
• Valproate activates the Snf1 kinase in Saccharomyces cerevisiae by decreasing the cytosolic pH

  2021cites this paper
• Polypharmacy in Clinical Psychiatry - A Brief Review

  2021cites this paper
• Psychopharmacotherapy of Pain

  2021cites this paper
• The effects of major depressive disorder symptoms on audiovisual integration

  2020cites this paper
• Evaluation of sodium valproate low dose efficacy in radicular pain management and it’s relation with pharmacokinetics parameters

  2020cites this paper
• Gamma-Aminobutyric Acid (GABA)

  2020cites this paper
• Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects

  2020cites this paper
• Altered expression of glutamatergic and GABAergic genes in the valproic acid-induced rat model of autism: a screening test.

  2020cites this paper
• The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins

  2020cites this paper
• On the diagnostic and neurobiological origins of bipolar disorder

  2020cites this paper
• Commentary and Update on the Contribution of the GABA Hypothesis to Understanding the Mechanism of Action of Electroconvulsive Therapy.

  2020cites this paper
• Valproate for acute mania.

  2019cites this paper
• Essential Pharmacotherapies for Bipolar Disorder

  2019cites this paper
• The molecular mechanism underlying GABAergic dysfunction in nucleus accumbens of depression‐like behaviours in mice

  2019cites this paper
• Retinal alterations in a pre-clinical model of an autism spectrum disorder

  2019cites this paper
• Does caffeine therapy improve cognitive impairments in valproic acid rat model of autism?

  2019cites this paper
• Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy

  2019cites this paper
• The Use of Larval Zebrafish (Danio rerio) Model for Identifying New Anxiolytic Drugs from Herbal Medicine

  2018cites this paper
• Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy.

  2018cites this paper
• Evaluation of Neurotransmitter Alterations in Four Distinct Brain Regions After Rapid Eye Movement Sleep Deprivation (REMSD) Induced Mania-Like Behaviour in Swiss Albino Mice

  2018cites this paper
• Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression.

  2018cites this paper
• The valproic acid-induced rodent model of autism.

  2018cites this paper
• A History of the Pharmacological Treatment of Bipolar Disorder

  2018cites this paper
• The role of gamma-aminobutyric acid in female depression

  2017cites this paper
• Meta-analysis of central and peripheral &ggr;-aminobutyric acid levels in patients with unipolar and bipolar depression

  2017cites this paper
• Catatonia in Psychiatric Illnesses

  2016cites this paper
• The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm

  2016cites this paper
• Efficacy of Anti-Epileptic Drugs in the Treatment of Tumor and Its Associated Epilepsy: An in vitro Perspective

  2016cites this paper
• Depressive Disorders: Prevalence, Costs, and Theories

  2016cites this paper
• Inhibition in the Human Auditory Cortex

  2016cites this paper
• Development of psychopathology in deployed armed forces in relation to plasma GABA levels.

  2016cites this paper
• Deficits in the 30-Hz auditory steady-state response in patients with major depressive disorder

  2016cites this paper
• GABA, Depression and Suicide

  2015cites this paper
• Bipolar (Manic Depressive) Disorders

  2015cites this paper
• Akutbehandlung manischer Episoden

  2015cites this paper
• Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid

  2015cites this paper
• Developing piezoelectric biosensing methods

  2015cites this paper
• Neuroprotective effects of histone deacetylase inhibitors in brain ischemia.

  2014cites this paper
• Why Are Cortical GABA Neurons Relevant to Internal Focus in Depression? A cross-level model linking cellular, biochemical, and neural network findings

  2014cites this paper
• Altered GABA function in Major Depression

  2014cites this paper
• Repurposed drugs for the treatment of schizophrenia and bipolar disorders.

  2013cites this paper
• Chemotherapy in psychiatry

  2013cites this paper
• Mood-Stabilizing Agents

  2013cites this paper
• Short- and long-term effects of juvenile stressor exposure on the expression of GABAA receptor subunits in rats

  2012cites this paper
• Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry

  2012cites this paper
• Gamma Band Neural Synchronization Deficits for Auditory Steady State Responses in Bipolar Disorder Patients

  2012cites this paper
• Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant-like effect in the rat forced swim test.

  2011cites this paper
• Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

  2011cites this paper
• Is Anticonvulsant Treatment of Mania a Class Effect? Data from Randomized Clinical Trials

  2011cites this paper
• GABAB receptors and depression. Current status.

  2010cites this paper
• Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies.

  2010cites this paper
• GABA and Homovanillic Acid in the Plasma of Schizophrenic and Bipolar I Patients

  2010cites this paper
• Modulation of ion channels in clinical psychopharmacology: adults and younger people

  2010cites this paper
• The GABAB receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats

  2010cites this paper
• Neurotransmitter Systems in Bipolar Disorder

  2010cites this paper
• Reduced Expression of GABA Transporter GAT3 in Helpless Rats, an Animal Model of Depression

  2009cites this paper
• Enhanced Visual Motion Perception in Major Depressive Disorder

  2009cites this paper
• Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection.

  2009cites this paper
• Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation.

  2009cites this paper
• Neuronal circuit‐dependent alterations in expression of two isoforms of glutamic acid decarboxylase in the hippocampus following electroconvulsive shock: A stereology‐based study

  2009cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

  2009cites this paper
• Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?

  2008cites this paper
• Medikamente zur Behandlung bipolarer affektiver Störungen

  2008cites this paper
• Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.

  2008cites this paper
• Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA.

  2007cites this paper
• Role of GABA in anxiety and depression

  2007cites this paper
• [Cortico-limbic mechanisms of affect regulation in the therapy of depression].

  2007cites this paper
• [Clinical standing of valproate treatment of bipolar disorders].

  2007cites this paper
• [Official guidelines for the treatment of acute mania].

  2006cites this paper
• Cerebrospinal fluid GABA levels in chronic migraine with and without depression.

  2006cites this paper
• Litio: 55 años de historia en el tratamiento del trastorno bipolar

  2006cites this paper
• Open-label tiagabine monotherapy for major depressive disorder with anxiety.

  2006cites this paper
• [Lithium: 55 years of history in the therapy of bipolar affective disorder].

  2006cites this paper
• Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications

  2006cites this paper
• Antidepressant‐like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents

  2006cites this paper
• Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders

  2006cites this paper
• Are autistic and catatonic regression related? A few working hypotheses involving gaba, Purkinje cell survival, neurogenesis, and ECT.

  2006cites this paper
• [Valproate sustained release in the treatment of epilepsy].

  2005cites this paper
• Zentralnervöse Nebenwirkungen verschiedener antibakterieller Substanzen

  2005cites this paper
• Is there a connection between autism, Prader-Willi syndrome, catatonia, and GABA?

  2005cites this paper
• Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.

  2005cites this paper
• GABA and glutamate systems as therapeutic targets in depression and mood disorders

  2005cites this paper
• Bipolar disorder.

  2004cites this paper
• Lamotrigine in the treatment of confusion psychosis. A case report.

  2004cites this paper
• What is a "mood stabilizer"? An evidence-based response.

  2004cites this paper
• EEG-Veränderungen akut manischer Patienten unter hohen Dosen Propranolol

  2004cites this paper
• Asthma medication may influence the psychological functioning of children.

  2004cites this paper
• Invited review: the evolution of antidepressant mechanisms

  2004cites this paper
• Differing psychotropic profiles of the anticonvulsants in bipolar and other psychiatric disorders

  2004cites this paper